These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32443836)

  • 1. Clinical and Molecular Data Define a Diagnosis of Arrhythmogenic Cardiomyopathy in a Carrier of a Brugada-Syndrome-Associated
    Persampieri S; Pilato CA; Sommariva E; Maione AS; Stadiotti I; Ranalletta A; Torchio M; Dello Russo A; Basso C; Pompilio G; Tondo C; Casella M
    Genes (Basel); 2020 May; 11(5):. PubMed ID: 32443836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype.
    Cerrone M; Lin X; Zhang M; Agullo-Pascual E; Pfenniger A; Chkourko Gusky H; Novelli V; Kim C; Tirasawadichai T; Judge DP; Rothenberg E; Chen HS; Napolitano C; Priori SG; Delmar M
    Circulation; 2014 Mar; 129(10):1092-103. PubMed ID: 24352520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arrhythmogenic cardiomyopathy and provocable Brugada ECG in a patient caused by missense mutation in plakophilin-2.
    Peters S
    Int J Cardiol; 2014 May; 173(2):317-8. PubMed ID: 24681023
    [No Abstract]   [Full Text] [Related]  

  • 4. Is Brugada syndrome a variant of arrhythmogenic cardiomyopathy?
    Peters S
    Int J Cardiol; 2015; 189():88-90. PubMed ID: 25889434
    [No Abstract]   [Full Text] [Related]  

  • 5. Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Dalal D; James C; Devanagondi R; Tichnell C; Tucker A; Prakasa K; Spevak PJ; Bluemke DA; Abraham T; Russell SD; Calkins H; Judge DP
    J Am Coll Cardiol; 2006 Oct; 48(7):1416-24. PubMed ID: 17010805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of two edited iPSCs lines by CRISPR/Cas9 with point mutations in PKP2 gene for arrhythmogenic cardiomyopathy in vitro modeling.
    Amin G; Castañeda SL; Zabalegui F; Belli C; Atorrasagasti C; Miriuka SG; Moro LN
    Stem Cell Res; 2023 Sep; 71():103157. PubMed ID: 37393721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epicardial Ventricular Tachycardia Ablation in a Patient With Brugada ECG Pattern and Mutation of PKP2 and DSP Genes.
    Forkmann M; Tomala J; Huo Y; Mayer J; Christoph M; Wunderlich C; Salmas J; Gaspar T; Piorkowski C
    Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):505-7. PubMed ID: 25900994
    [No Abstract]   [Full Text] [Related]  

  • 8. Brugada Syndrome and PKP2: Evidences and uncertainties.
    Campuzano O; Fernández-Falgueras A; Iglesias A; Brugada R
    Int J Cardiol; 2016 Jul; 214():403-5. PubMed ID: 27085656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmosomes and the sodium channel complex: implications for arrhythmogenic cardiomyopathy and Brugada syndrome.
    Cerrone M; Delmar M
    Trends Cardiovasc Med; 2014 Jul; 24(5):184-90. PubMed ID: 24656989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MYH10 activation rescues contractile defects in arrhythmogenic cardiomyopathy (ACM).
    García-Quintáns N; Sacristán S; Márquez-López C; Sánchez-Ramos C; Martinez-de-Benito F; Siniscalco D; González-Guerra A; Camafeita E; Roche-Molina M; Lytvyn M; Morera D; Guillen MI; Sanguino MA; Sanz-Rosa D; Martín-Pérez D; Garcia R; Bernal JA
    Nat Commun; 2023 Oct; 14(1):6461. PubMed ID: 37833253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical profile in arrhythmogenic cardiomyopathy and a recessive plakophilin-2 gene mutation.
    Ali M; Bhat IA; Hafeez I; Dar MI; Beig JR; Shah ZA; Iqbal K
    Indian Heart J; 2018; 70(3):421-426. PubMed ID: 29961461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Autopsy of Desmosomal Protein Plakophilin-2 in Sudden Unexplained Nocturnal Death Syndrome.
    Huang L; Tang S; Peng L; Chen Y; Cheng J
    J Forensic Sci; 2016 May; 61(3):687-91. PubMed ID: 27122407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Genotype on Structural Atrial Abnormalities and Atrial Fibrillation or Flutter in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
    Bourfiss M; Te Riele AS; Mast TP; Cramer MJ; VAN DER Heijden JF; VAN Veen TA; Loh P; Dooijes D; Hauer RN; Velthuis BK
    J Cardiovasc Electrophysiol; 2016 Dec; 27(12):1420-1428. PubMed ID: 27572111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Truncating plakophilin-2 mutations in arrhythmogenic cardiomyopathy are associated with protein haploinsufficiency in both myocardium and epidermis.
    Rasmussen TB; Nissen PH; Palmfeldt J; Gehmlich K; Dalager S; Jensen UB; Kim WY; Heickendorff L; Mølgaard H; Jensen HK; Baandrup UT; Bross P; Mogensen J
    Circ Cardiovasc Genet; 2014 Jun; 7(3):230-40. PubMed ID: 24704780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of plakophilin-2 in Chinese with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Qiu X; Liu W; Hu D; Zhu T; Li C; Li L; Guo C; Liu X; Wang L; Zheng H; Wang C; Diao Q; Shi D; Zhan P; Deng Y; Liu K; Wang Y; Liu B; Liu H; Zhang L
    Am J Cardiol; 2009 May; 103(10):1439-44. PubMed ID: 19427443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive Reduction in Right Ventricular Contractile Function Attributable to Altered Actin Expression in an Aging Mouse Model of Arrhythmogenic Cardiomyopathy.
    Camors EM; Roth AH; Alef JR; Sullivan RD; Johnson JN; Purevjav E; Towbin JA
    Circulation; 2022 May; 145(21):1609-1624. PubMed ID: 35437032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left-dominant arrhythmogenic cardiomyopathy in a large family: associated desmosomal or nondesmosomal genotype?
    Groeneweg JA; van der Zwaag PA; Jongbloed JD; Cox MG; Vreeker A; de Boer RA; van der Heijden JF; van Veen TA; McKenna WJ; van Tintelen JP; Dooijes D; Hauer RN
    Heart Rhythm; 2013 Apr; 10(4):548-59. PubMed ID: 23270881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    van Tintelen JP; Entius MM; Bhuiyan ZA; Jongbloed R; Wiesfeld AC; Wilde AA; van der Smagt J; Boven LG; Mannens MM; van Langen IM; Hofstra RM; Otterspoor LC; Doevendans PA; Rodriguez LM; van Gelder IC; Hauer RN
    Circulation; 2006 Apr; 113(13):1650-8. PubMed ID: 16567567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2.
    Dalal D; Molin LH; Piccini J; Tichnell C; James C; Bomma C; Prakasa K; Towbin JA; Marcus FI; Spevak PJ; Bluemke DA; Abraham T; Russell SD; Calkins H; Judge DP
    Circulation; 2006 Apr; 113(13):1641-9. PubMed ID: 16549640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plakophilin-2 missense mutations in arrhythmogenic right ventricular cardiomyopathy.
    Lahtinen AM; Lehtonen A; Kaartinen M; Toivonen L; Swan H; Widén E; Lehtonen E; Lehto VP; Kontula K
    Int J Cardiol; 2008 May; 126(1):92-100. PubMed ID: 17521752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.